Literature DB >> 3924278

Rational drug treatment of dementia?

J Byrne, T Arie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3924278      PMCID： PMC1416761          DOI： 10.1136/bmj.290.6485.1845

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  17 in total

1.  Alzheimer's disease as a disorder of isodendritic core.

Authors:  J S Benton; D M Bowen; S J Allen; E A Haan; A N Davison; D Neary; R P Murphy; J S Snowden
Journal:  Lancet       Date:  1982-02-20       Impact factor: 79.321

2.  Hydergine: a review of 26 clinical studies.

Authors:  R J McDonald
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1979-11

3.  Choline in Alzheimers disease.

Authors:  R Levy
Journal:  Lancet       Date:  1978-10-28       Impact factor: 79.321

4.  Effects of vasopressin on memory and new learning in a brain-injured population.

Authors:  W D Fewtrell; A O House; P F Jamie; M R Oates; J E Cooper
Journal:  Psychol Med       Date:  1982-05       Impact factor: 7.723

5.  Effects of vasopressin on human memory functions.

Authors:  H Weingartner; P Gold; J C Ballenger; S A Smallberg; R Summers; D R Rubinow; R M Post; F K Goodwin
Journal:  Science       Date:  1981-02-06       Impact factor: 47.728

6.  Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

Authors:  E K Perry; B E Tomlinson; G Blessed; R H Perry; A J Cross; T J Crow
Journal:  J Neurol Sci       Date:  1981-08       Impact factor: 3.181

7.  Changes in the monoamine containing neurones of the human CNS in senile dementia.

Authors:  D M Mann; J Lincoln; P O Yates; J E Stamp; S Toper
Journal:  Br J Psychiatry       Date:  1980-06       Impact factor: 9.319

8.  A new definition of Alzheimer's disease: a hippocampal dementia.

Authors:  M J Ball; M Fisman; V Hachinski; W Blume; A Fox; V A Kral; A J Kirshen; H Fox; H Merskey
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

9.  Decreased imipramine binding in the brains of patients with depressive illness.

Authors:  E K Perry; E F Marshall; G Blessed; B E Tomlinson; R H Perry
Journal:  Br J Psychiatry       Date:  1983-02       Impact factor: 9.319

10.  Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.

Authors:  P Davies; R Katzman; R D Terry
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.